Nuvation Bio NUVB
NYSE NUVB
$4.74 -0.11 (-2.16%)
As of: Oct 22, 2026 · 10:58 AM EDT

Nuvation Bio (NUVB) Preferred Shares (2024)

Updated

Nuvation Bio's Preferred Shares was $274.94 million in Q2 2024.

Analysis

Nuvation Bio (NUVB) Preferred Shares (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Eli Lilly 1,167.56 Bn 1,136.14 Bn 19.71 Bn -
2 Johnson & Johnson 635.76 Bn 554.29 Bn 17.26 Bn -
3 AbbVie 503.27 Bn 476.38 Bn 12.70 Bn -
4 Merck 377.51 Bn 331.89 Bn 12.21 Bn -
5 Novartis Ag 304.07 Bn 268.06 Bn 11.24 Bn -
6 Astrazeneca 267.53 Bn 241.22 Bn 12.86 Bn -
7 Amgen 242.06 Bn 197.46 Bn 7.24 Bn -
8 Gilead Sciences 194.26 Bn 168.46 Bn 6.22 Bn -
9 Pfizer 172.62 Bn 119.27 Bn 10.94 Bn -
10 Nuvation Bio 1.65 Bn -619.77 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 274.94 Mn
API Access

Nuvation Bio Preferred Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-shares&ticker=NUVB&period=max&api_key=YOUR_API_KEY